Rare diseases
Investigational molecules
Locations
Back to Ireland324 clinical trials in Drogheda, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
IrelandStudy on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)
IrelandStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
IrelandStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
IrelandStudy of trastuzumab deruxtecan treatment in patients with advanced HER2-positive breast cancer with or without brain metastases
IrelandStudy on the Effects of Semaglutide in Patients with Early Alzheimer's Disease
IrelandStudy of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
IrelandStudy on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
IrelandStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
IrelandStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
IrelandStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
IrelandStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
IrelandThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on inflammatory bowel diseases, including trials evaluating new therapeutic approaches for ulcerative colitis and Crohn's disease. Studies are examining novel compounds like obefazimod for improving patient outcomes.
Multiple trials are investigating endoscopic improvement and symptomatic remission in patients with moderate to severe conditions.
Groundbreaking research in preventing and treating various infections, with particular focus on Clostridioides difficile infection recurrence and surgical site infections following abdominal procedures.
Studies are evaluating novel preventive measures and treatment approaches to reduce infection rates.
Clinical research examining treatments for chronic skin conditions, with emphasis on Hidradenitis Suppurativa. Trials are evaluating new biological therapies like lutikizumab for moderate to severe cases.
Research focuses on improving symptoms and quality of life for patients with persistent skin disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
